MA40496A - Capsacinoïdes et leurs utilisations en tant que médicaments - Google Patents

Capsacinoïdes et leurs utilisations en tant que médicaments

Info

Publication number
MA40496A
MA40496A MA040496A MA40496A MA40496A MA 40496 A MA40496 A MA 40496A MA 040496 A MA040496 A MA 040496A MA 40496 A MA40496 A MA 40496A MA 40496 A MA40496 A MA 40496A
Authority
MA
Morocco
Prior art keywords
capsaicinoids
medicaments
medicament
treatment
capsaicinoid
Prior art date
Application number
MA040496A
Other languages
English (en)
Inventor
Mandishora Israel Muzari
Original Assignee
Mandishora Israel Muzari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014903253A external-priority patent/AU2014903253A0/en
Application filed by Mandishora Israel Muzari filed Critical Mandishora Israel Muzari
Publication of MA40496A publication Critical patent/MA40496A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un médicament contenant un capsacinoïde, possédant une activité antivirale et utile dans le traitement d'infections virales et dans le traitement du vih/sida. Le médicament présente également une activité d'amélioration de la neuroplasticité et est utile dans le traitement du stress et d'autres conditions psychologiques. De plus, le médicament possède une activité anti-inflammatoire et est utile dans le traitement de l'arthrite. Le médicament a aussi montré qu'il possède une
MA040496A 2014-08-19 2015-07-31 Capsacinoïdes et leurs utilisations en tant que médicaments MA40496A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2014903253A AU2014903253A0 (en) 2014-08-19 Viral therapy

Publications (1)

Publication Number Publication Date
MA40496A true MA40496A (fr) 2017-06-28

Family

ID=55349992

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040496A MA40496A (fr) 2014-08-19 2015-07-31 Capsacinoïdes et leurs utilisations en tant que médicaments

Country Status (8)

Country Link
US (1) US20170239198A1 (fr)
EP (1) EP3182968A4 (fr)
KR (1) KR20170066344A (fr)
AU (1) AU2015306063A1 (fr)
CA (1) CA2961766A1 (fr)
EA (1) EA201700114A1 (fr)
MA (1) MA40496A (fr)
WO (1) WO2016025977A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019008239A2 (pt) 2016-11-02 2019-07-16 Centrexion Therapeutics Corp formulações aquosas, estáveis, injetáveis de capsaicina e uso médicos dos mesmos
AU2018302342B2 (en) 2017-07-20 2024-08-08 Centrexion Therapeutics Corporation Methods and compositions for treatment of pain using capsaicin
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) * 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US20030082249A1 (en) * 2001-10-26 2003-05-01 Ovation Pharmaceuticals Compositions containing capsaicin and its derivatives, and their use in treating mucositis
FR2849992B1 (fr) * 2003-01-17 2007-03-16 Inst Phytoceutic Composition pour une administration par voie orale contenant des capsaicinoides
US20040224037A1 (en) * 2003-04-28 2004-11-11 Gonzalo Romero-Matos Devastating treatment against hiv/aids with capsaicin

Also Published As

Publication number Publication date
EP3182968A4 (fr) 2018-05-09
EP3182968A1 (fr) 2017-06-28
US20170239198A1 (en) 2017-08-24
EA201700114A1 (ru) 2017-06-30
KR20170066344A (ko) 2017-06-14
WO2016025977A1 (fr) 2016-02-25
AU2015306063A1 (en) 2017-04-13
CA2961766A1 (fr) 2016-02-25

Similar Documents

Publication Publication Date Title
HK1253882A1 (zh) 用於hiv感染的rna導向治療的方法和組合物
ZA201708692B (en) Antibacterial compounds
EP3420077A4 (fr) Traitement au moyen d'une nucléase virale et oncovirale
MX2020005187A (es) Compuestos y composiciones farmaceuticas antivirales, asi como metodos de uso de los mismos.
IL246117A0 (en) Administration, use and therapeutic applications of crispr-cas systems and preparations for HBV and viral diseases and disorders
HK1246296A1 (zh) 多環氨基甲酰基吡啶酮化合物和其用於治療hiv感染的用途
HK1246295A1 (zh) 多環氨基甲酰基吡啶酮化合物和其用於治療hiv感染的用途
HK1247963A1 (zh) 用於hiv的治療的基因療法及其用途
IL263368A (en) Prevention and treatment of viral infections
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
MA40496A (fr) Capsacinoïdes et leurs utilisations en tant que médicaments
HRP20181582T1 (hr) Formulacija atazanavira i kobicistata za liječenje hiv-a
MX2016002560A (es) Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
IN2014MU00916A (fr)
SG11202011775VA (en) Antiviral treatment of flavivirus infection
MX2016000037A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
EP3017816A4 (fr) Médicament à base de diindolylméthane et son utilisation pour traiter la grippe et les infections virales respiratoires
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
SG10202010317VA (en) Pyrimidine prodrugs for the treatment of viral infections and further diseases
CA161044S (en) Temporary skin tattoo for your eyebrows
WO2015134166A9 (fr) Utilisation de n-acétylcystéine amide dans le traitement du syndrome d'immunodéficience acquise et d'une infection par le vih
TH1501003876A (th) วัคซีนของไทรเมอร์ของถุงหุ้ม (Env) ของไวรัสโรคภูมิคุ้มกันบกพร่องของ มนุษย์ซึ่งทำให้เกิดเสถียรภาพ (HIV) และวิธีการของการใช้ที่เหมือนกัน
GB201400760D0 (en) Use of geneticaly modified virus in order to remove viral latency shown on HIV example